About GenoKeys

GenoKeys is a biotech company based in Barcelona, Spain, spin-off of the Neurovascular Research Laboratory of the Research Institute of the Vall d’Hebron Hospital. GenoKeys is dedicated to the research and development of predictive tools in the fields of neurological diseases and genetics. At the moment, GenoKeys is focused on the development of tools to be used as indicators of a person’s risk of ischemic stroke.

About Stroke

Stroke is a sudden disruption of cerebral blood flow caused by occlusion or rupture of brain vessels. The cerebral damage caused by a stroke is immediate and can be devastating, depending on how fast it is diagnosed and treated, the type of infarct and the patient’s evolution. Typical stroke symptoms can include sudden numbness or paralysis in the face or body, typically in one side only, as well as loss of equilibrium or sight, severe headache, dizziness, impaired speech and understanding. These neurological deficits depend on the brain’s area affected .

In recent years, death rates from cardiovascular diseases have declined, yet the burden remains high, with a 2005 overall rate of 280 per 100 000 habitants. About 795 000 people experience a new or recurrent stroke each year, making it the third cause of death in industrialized countries, behind myocardial infarction and cancer. The incidence is approximately 100 times higher in the aging population (over 65 years of age). Stroke is also the first cause of adult disability and it is estimated that 4/5 families will be somehow affected by stroke over the course of a lifetime.